Insulet | PODD - Loan Capital


Insulet reported $930.8M in Loan Capital for its fiscal quarter ending in December of 2025.





Loan Capital Change Date
Abbott USD 9.9B 1.7B Dec/2025
Align Technology USD 0 0 Dec/2024
AtriCure USD 61.86M 0 Dec/2025
Avanos Medical USD 90.3M 3.1M Dec/2025
Baxter International USD 9.47B 726M Dec/2025
Becton, Dickinson and Co. USD 16.92B 705M Dec/2025
Boston Scientific USD 10.99B 12M Sep/2025
Cardinal Health USD 8.35B 633M Dec/2025
Cooper Companies USD 2.46B 26.1M Sep/2025
Dexcom USD 1.24B 53.6M Dec/2025
Edwards Lifesciences USD 598.2M 200K Sep/2025
Eli Lilly USD 40.87B 5.6M Dec/2025
Globus Medical USD 427K 254K Sep/2025
ICU Medical USD 1.27B 48.01M Dec/2025
Inogen USD 0 0 Jun/2022
Insulet USD 930.8M 4.1M Dec/2025
Integra LifeSciences USD 1.86B 63.76M Dec/2025
J&J USD 39.44B 30M Dec/2025
Masimo USD 559.1M 39.6M Sep/2025
Medtronic USD 27.62B 1.45B Sep/2025
Merit Medical Systems USD 734.04M 1.12M Dec/2025
Roche Holding CHF 27.43B 966M Dec/2025
Solventum Corp USD 5.04B 102M Dec/2025
Stryker USD 14.86B 14M Dec/2025
Tandem Diabetes Care USD 310.04M 446K Dec/2025
Teleflex USD 2.54B 30.06M Dec/2025
West Pharmaceutical Services USD 202.8M 100K Dec/2025
Zimmer Biomet Holdings USD 6.93B 580.6M Dec/2025